Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment

MLA

Fabio Malavasi, et al. “Anti-CD73 Immunotherapy: A Viable Way to Reprogram the Tumor Microenvironment.” OncoImmunology, vol. 5, July 2016, p. e1216292. EBSCOhost, https://doi.org/10.1080/2162402x.2016.1216292.

APA

Fabio Malavasi, Davide Ferrari, Luca Antonioli, György Haskó, & Corrado Blandizzi. (2016). Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment. OncoImmunology, 5, e1216292. https://doi.org/10.1080/2162402x.2016.1216292

Chicago

Fabio Malavasi, Davide Ferrari, Luca Antonioli, György Haskó, and Corrado Blandizzi. 2016. “Anti-CD73 Immunotherapy: A Viable Way to Reprogram the Tumor Microenvironment.” OncoImmunology 5 (July): e1216292. doi:10.1080/2162402x.2016.1216292.